Stay updated with breaking news from Torsten Falk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have developed a new class of drugs that is able to cross the blood-brain barrier. The technology has been licensed to the startup Teleport Pharmaceuticals.
PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease May 17, 2021 07:59 ET | Source: PharmaTher Holdings Ltd. PharmaTher Holdings Ltd. Vancouver, British Columbia, CANADA TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a psychedelics biotech company, is pleased to announce that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s Investigational New Drug (“IND”) application to proceed with a Ph...
PharmaTher Granted Pre-IND Meeting with the FDA for Ketamine in Parkinson’s Disease December 10, 2020 07:00 ET | Source: Newscope Capital Corporation Newscope Capital Corporation Vancouver, British Columbia, CANADA TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) -- PharmaTher Inc., (“PharmaTher” or the “Company”), a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTC Pink: PHRRF) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that it has be...